Inovio Pharmaceuticals (INO) Interest Coverage Ratio (2011 - 2026)
Inovio Pharmaceuticals (INO) posted Interest Coverage Ratio of 10.3 for Q1 2026, down 461.9% sequentially from 1.83 in Q1 2025, and down 461.9% YoY from 2.84 in Q1 2025.
Inovio Pharmaceuticals (INO) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Inovio Pharmaceuticals has reported Interest Coverage Ratio for 16 years, with the latest figure at 10.3 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 461.9% year-over-year to 10.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 39.27 (down 406.67% YoY) and the FY2025 annual result came in at 0.23, up 28.73% from the prior year.
- Interest Coverage Ratio declined to 10.3 in Q1 2026 per INO's latest filing, from 1.83 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 121973.42 in Q4 2024 and troughed at 332.19 in Q2 2022.
- A 5-year average of 10069.05 and a median of 92.52 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2024 and 2026: Interest Coverage Ratio jumped 118973.34% in 2024, then sank 461.9% in 2026.
- Over 5 years, Interest Coverage Ratio stood at 76.32 in 2022, then sank by 34.44% to 102.61 in 2023, then surged by 118973.34% to 121973.42 in 2024, then sank by 100.0% to 1.83 in 2025, then tumbled by 461.9% to 10.3 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 10.3, 1.83, and 121973.42 for Q1 2026, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Inovio Pharmaceuticals | 97.94 Mn | 97.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.01 |
| Mar 31, 2026 | -10.30 |
| Mar 31, 2025 | -1.83 |
| Dec 31, 2024 | 121,973.42 |
| Mar 31, 2024 | -59.02 |
| Dec 31, 2023 | -102.61 |
| Sep 30, 2023 | -113.41 |
| Jun 30, 2023 | -118.16 |
| Mar 31, 2023 | -82.43 |
| Dec 31, 2022 | -76.32 |
| Sep 30, 2022 | -114.06 |
| Jun 30, 2022 | -332.19 |
| Mar 31, 2022 | -134.46 |
| Dec 31, 2021 | 278.88 |
| Sep 30, 2021 | -125.85 |
| Jun 30, 2021 | -178.27 |
| Mar 31, 2021 | -96.55 |
| Dec 31, 2020 | -27.47 |
| Sep 30, 2020 | -18.31 |
| Jun 30, 2020 | -11.66 |